Mediprime

What Mediprime does

Mediprime (legal entity MEDIPRIME SA) is a Greek healthcare organization specializing in chronic kidney disease (CKD) treatment and renal care products, operating as the exclusive authorized distributor of Fresenius Medical Care in Greece. Founded in the early 1970s and headquartered in Marousi with a warehouse in Koropi and branch offices in Thessaloniki, Heraklion (Crete), and Messinia (Peloponnese), the company is family-led by President Dimitrios Dimitriadis M.D. and Vice President George Dimitriadis M.D. It self-describes as the largest provider of healthcare solutions for people with chronic kidney failure in Greece.

The company's product portfolio spans three categories: (1) medical devices covering hemodialysis machines (5008 CorDiax, 4008S classix), dialyzers (F-series, FX-class), peritoneal dialysis systems (sleep-safe APD, stay-safe CAPD), pediatric dialysis solutions (PD-Paed Plus, 5008 CorDiax Paed), acute CRRT systems (multiFiltrate), and therapeutic apheresis (DALI); (2) CKD pharmaceuticals including Sevelamer Carbonate, Paricalcitol, and Cinacalcet; and (3) B2B services for hospitals and dialysis clinics covering project planning, turnkey construction, technical maintenance, and operational management. Customers are Greek hospitals, dialysis clinics, and ICU/acute care units, with end-use cases spanning hemodialysis, peritoneal dialysis, CRRT, pediatric dialysis, and therapeutic apheresis.

Mediprime generates revenue through hardware sales of dialysis equipment, recurring consumables (dialyzers, bloodlines, concentrates), pharmaceutical sales, professional service contracts for facility planning and management, and distribution margin on FMC products. Pricing is quote-based and not publicly disclosed. The go-to-motion combines direct enterprise field sales to healthcare facilities with a value-added channel partnership with Fresenius Medical Care. The company is privately held, with no disclosed institutional investors, funding rounds, M&A, or plans for international expansion.

Name

Mediprime

Legal name

MEDIPRIME SA

Website

https://mediprime.gr

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

51–100 employees

Short description

Mediprime is the exclusive distributor of Fresenius Medical Care products in Greece, supplying dialysis equipment, consumables, CKD pharmaceuticals, and facility management services to hospitals and dialysis clinics nationwide.

Ownership category

akta.pro rank

Product category

Dialysis Medical Devices and Renal Care Products

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI)

Keywords

• Dialysis equipment distribution
• Chronic kidney disease
• Hemodialysis products
• Medical device distribution
• Renal care pharmaceuticals

Headquarters

HQ city

Maroúli

HQ country

Greece

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Medical Devices Distribution: Distribution of hemodialysis machines, dialyzers, bloodline systems, water treatment systems, and related dialysis equipment. Revenue generated through product sales to hospitals and dialysis clinics.
2. Pharmaceutical Sales: Sale of pharmaceutical products for chronic kidney disease treatment including Sevelamer Carbonate, Paricalcitol, and Cinacalcet to healthcare providers and patients.
3. Business Services: B2B services for hospitals and dialysis clinics covering project planning, turnkey construction, technical maintenance, and total operational management. Revenue from service contracts with healthcare facilities.
4. Distribution Partnership Revenue: Revenue from distribution of Fresenius Medical Care products as their authorized distributor in Greece, including ongoing product supply and support services.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Mediprime (MEDIPRIME SA) is the authorized distributor of Fresenius Medical Care dialysis products in Greece, supplying hemodialysis, peritoneal dialysis, pediatric dialysis, acute therapies (CRRT, plasmapheresis) and therapeutic apheresis equipment to hospitals and dialysis clinics nationwide. The company also markets a CKD-focused pharmaceutical portfolio (Sevelamer Carbonate, Paricalcitol, Cinacalcet) and provides B2B business services covering project planning, turnkey construction, technical maintenance, and total operational management of dialysis facilities.

Product overview

Mediprime is a leading healthcare organization providing a comprehensive portfolio of products for chronic kidney disease treatment, operating as a distributor of Fresenius Medical Care products in Greece. The product portfolio spans three main categories: (1) Medical Devices including hemodialysis machines (5008 CorDiax, 4008S classix), dialysers (F-series, FX-class), peritoneal dialysis systems (sleep•safe, stay•safe), pediatric dialysis solutions, acute therapies (multiFiltrate, CRRT filters, CRRT fluids), and therapeutic apheresis (DALI®); (2) Pharmaceuticals including Sevelamer Carbonate, Paricalcitol, and Cinacalcet for renal disease management; and (3) Business Services covering project planning, turnkey construction, technical maintenance, and operational management for hospitals and dialysis clinics. The company positions itself as a vertically integrated organization covering the entire dialysis value chain.

Differentiator

Problem solved

Functional benefit

Products and services

• Hemodialysis machines (5008 CorDiax, 5008S CorDiax and 4008S classix) Capital hemodialysis equipment from Fresenius Medical Care covering ONLINE hemodiafiltration (HDF) (5008 CorDiax) and cost-efficient, reliable HD treatment (4008S classix), sold to hospitals and dialysis clinics in Greece.
• F-series and FX-class dialysers (Polysulfone and Helixone membranes) with DIASAFE plus filter Dialysers (F-series Polysulfone and FX-class Helixone) plus the DIASAFE plus ultrapure dialysis fluid filter, providing biocompatible, high-endotoxin-retention membranes and safe fluid production for hemodialysis units.
• Hemodialysis consumables (fistula needles, bloodlines, bicarbonate concentrates, disinfectants) High-haemocompatibility fistula needles and bloodline tubing systems, bicarbonate concentrates in flexible bag packaging, and Citrosteril / Puristeril plus disinfectants for heat and cold disinfection of haemodialysis machines.
• Peritoneal dialysis systems (sleep-safe APD and stay-safe CAPD) Automated (APD) and Continuous Ambulatory (CAPD) peritoneal dialysis systems from Fresenius Medical Care, designed for safe, low-contamination home and clinic treatment with guided operation and safety-lock features.
• Peritoneal dialysis fluids (bicaVera, Balance, CAPD/DPCA) and BCM Body Composition Monitor Bicarbonate-buffered (bicaVera), pH-neutral (Balance) and standard (CAPD/DPCA) PD fluids together with the BCM Body Composition Monitor for non-invasive fluid status and muscle mass assessment in PD patients.
• Pediatric dialysis systems (PD-Paed Plus, 5008 CorDiax Paed, pediatric multiFiltrate) Specialized pediatric renal-replacement equipment including preassembled manual PD (PD-Paed Plus), hemodialysis from 17 kg (5008 CorDiax Paed), and pediatric CRRT (multiFiltrate with Ultraflux AVpaed haemofilter) for neonates, infants and children.
• Acute therapies (multiFiltrate CRRT system with Ultraflux CRRT filters and Ci-Ca / multiBic fluids, PlasmaFlux filter, Sodium Citrate 4%) MultiFiltrate platform for CRRT modalities (Ci-Ca CVVHD, CVVHDF, CVVH, plasmapheresis) with heparin or citrate anticoagulation, complemented by Ultraflux CRRT filters (AVpaed, AV400S, AV600S, AV1000S, EMiC 2), PlasmaFlux plasmapheresis filter, and multiBic / Ci-Ca bicarbonate-based CRRT fluids and Sodium Citrate 4% anticoagulant.
• DALI Lipoprotein Apheresis system Direct adsorption lipoprotein apheresis technology for substantially reducing high cholesterol and lipoprotein(a) levels in patient bloodstream, featuring highly selective LDL-C and Lp(a) removal with short treatment times for severe hypercholesterolemia and elevated Lp(a).
• CKD pharmaceuticals (Sevelamer Carbonate, Paricalcitol, Cinacalcet) Focused renal pharmaceuticals: Sevelamer Carbonate for hyperphosphataemia control in dialysis patients, Paricalcitol for prevention and treatment of secondary hyperparathyroidism in chronic renal failure, and Cinacalcet for hyperparathyroidism secondary to chronic renal failure.
• Dialysis facility business services (project planning, turnkey construction, technical maintenance, operational management) End-to-end B2B services for hospitals and dialysis clinics covering project planning, turnkey construction, technical maintenance and total operational management of dialysis facilities, sold separately from the device and pharmaceutical offering.

Quantifiable outcome

• Substantially reduces high cholesterol levels through DALI lipoprotein apheresis treatment
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Fresenius Medical CarecoreChannel Partner/ Reseller/ DistributorMediprime serves as the authorized distributor of Fresenius Medical Care products in Greece. This long-standing alliance has grown steadily over the years, supported by mutual commitment and trust. The smooth collaboration has established Mediprime as the most respected and reliable player in the Greek renal care market, distributing FMC's complete range of dialysis machines, dialyzers, bloodlines, and therapeutic solutions.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• DaVita: Largest US/global dialysis service provider with extensive European clinic operations. Comparable on the renal managed-services side that Mediprime is expanding into via its operational-management offering.
• Fresenius Medical Care: Global dialysis products and services leader and Mediprime's principal supplier. It manufactures the very machines, dialysers, bloodlines, and PD systems that Mediprime distributes in Greece, making it the natural strategic counterpart.

Emerging players

• Toray Medical: Supplier of dialysis membranes (Polynephron) and blood purification technologies in Europe. Adjacent competitor in the dialyser and CRRT filter categories that Mediprime distributes.

Regional players

• Help Pharmaceuticals: Greek pharmaceutical manufacturer and distributor with broad hospital channel reach in Greece. Comparable on the Greek B2B pharmaceutical distribution dimension of Mediprime's business (CKD pharmaceuticals portfolio).

Direct peers

• Diaverum: Global independent dialysis services provider operating hundreds of clinics across Europe and emerging markets. Comparable to Mediprime on the renal-care services dimension and potential competitor for Greek managed-services contracts.
• Baxter (Vantive): Major supplier of peritoneal dialysis systems and fluids (e.g., HomeChoice, Amia, Dianeal), overlapping directly with Mediprime's sleep•safe/stay•safe and bicaVera PD offering.
• Nikkiso: Japanese producer of hemodialysis machines and blood purification systems active in European renal markets. Overlaps with Mediprime's hemodialysis and acute/CRRT product portfolio.
• Asahi Kasei Medical: Manufacturer of dialysis membranes (including APS series) and CRRT filters. Competes with the FX-class, F-series, and Ultraflux filter lines distributed by Mediprime.
• B. Braun Avitum: German manufacturer of hemodialysis machines, dialysers, and CRRT systems as well as a dialysis service provider. Competes head-to-head with the FMC portfolio that Mediprime distributes across hemodialysis and acute therapies.
• Nipro: Japanese manufacturer of dialysis machines, dialysers, and CKD pharmaceuticals; supplies renal-care consumables to European distributors and competes for the same hospital and clinic accounts that Mediprime serves.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mediprime-s.a.

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mediprime